DUPLEXOME
DEAD

Serial Number

88757515

Owner

TwinStrand Biosciences, Inc.

Attorney

Monica Riva Talley

Filing Date

Jan 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DUPLEXOME Trademark

Serial Number: 88757515

DUPLEXOME is a trademark filed by TwinStrand Biosciences, Inc. on January 13, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

TwinStrand Biosciences, Inc. (13 trademarks)

Suite 750
Seattle, WA 98121

Entity Type: 03

Trademark Details

Filing Date

January 13, 2020

Registration Date

Not Registered

Published for Opposition

April 7, 2020

Goods & Services

downloadable computer software for scientific and medical analysis of genetic sequences; downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, medical research, clinical research, molecular pathology, molecular diagnostics, biotechnology, oncology, genetics, pharmacology, forensics, genotoxicity, carcinogenesis, and consumer genomics; downloadable computer software for receiving, processing, transmitting and displaying data for use in genetic analysis

medical diagnostic reagents; clinical diagnostic reagents; diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing; medical diagnostic assays for medical and diagnostic purposes; medical diagnostic reagents and assays for testing body fluids; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes

kits comprising primarily of regents, enzymes and nucleotides for genetic research, forensic research, non-medical human identification, medical and scientific research; reagents, enzymes, and nucleotides for scientific or medical research use; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or medical research purposes; reagents for scientific or medical use, namely, reagents for use in preparation of DNA sequencing samples

Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; consulting and testing services in the field of genetic sequencing for medical, diagnostic and treatment purposes; providing medical genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases; providing a website featuring medically relevant information regarding genetics for educational purposes

Nucleic acid sequencing and analysis services for scientific and research purposes; genome sequencing and analysis services for scientific and research purposes; genetic analysis and reporting services for scientific and research purposes; genome sequencing and analysis services for forensic purposes; genome sequencing and analysis services for genotoxicity purposes; structural and functional analysis of genomes; medical and scientific research in the field of cancer detection, diagnosis and monitoring; providing medical and scientific information in the fields of pharmaceuticals and genetics; pharmaceutical research and development services; providing temporary use of non-downloadable computer software for scientific and medical analysis of genetic sequences; providing temporary use of non-downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, medical research, clinical research, molecular pathology, molecular diagnostics, biotechnology, oncology, genetics, pharmacology, forensics, genotoxicity, carcinogenesis, and consumer genomics

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 3, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 3, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2022 EXRA
SOU EXTENSION 5 GRANTED
Dec 12, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 12, 2022 AITU
SOU EXTENSION 5 FILED
Dec 1, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2022 EXRA
SOU EXTENSION 4 GRANTED
Apr 26, 2022 EX4G
SOU EXTENSION 4 FILED
Apr 26, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 26, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2021 EXRA
SOU EXTENSION 3 GRANTED
Nov 23, 2021 EX3G
SOU EXTENSION 3 FILED
Nov 23, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 23, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2021 EXRA
SOU EXTENSION 2 GRANTED
Apr 23, 2021 EX2G
SOU EXTENSION 2 FILED
Apr 23, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 23, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2020 EXRA
SOU EXTENSION 1 GRANTED
Nov 24, 2020 EX1G
SOU EXTENSION 1 FILED
Nov 24, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 24, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 3, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 3, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 3, 2020 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2020 CNSA
ASSIGNED TO EXAMINER
Feb 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2020 NWOS
NEW APPLICATION ENTERED
Jan 16, 2020 NWAP